Moteur de recherche d’entreprises européennes

Financement de l’UE (3 549 833 €) : Le Big Data au service de meilleurs résultats, de l’innovation politique et de la transformation du système de santé - Sofia réf. : 116055 Hor01/02/2017 Programme de recherche et d'innovation de l'UE « Horizon »

Vue d’ensemble

Texte

Le Big Data au service de meilleurs résultats, de l’innovation politique et de la transformation du système de santé - Sofia réf. : 116055

The overall goal of the Big Data for Better Outcomes (BD4BO) programme is to facilitate the use of ‘big data’ to promote the development of value-based, outcomes-focused healthcare systems in Europe. To fully exploit the transformative potential of big data, consideration will need to be taken of the use of detailed personal and biological information across the spectrum of care delivery, starting from the development of innovative medicines and treatments, to market access and adoption, diffusion, and use in healthcare systems by providers and patients. This paradigm shift requires shared understanding and standards among healthcare stakeholders including patients, providers, payers, regulators, policy makers, pharmaceutical industry, and academia. OBJECTIVES The proposed Coordination and Support Action (CSA) will establish an enabling platform that brings together these stakeholder groups across the BD4BO programme to ensure quality and consistency of individual projects in line with the overarching programme objective. Our consortium therefore aims to promote the use of big Data for better Outcomes, policy Innovation and healthcare system Transformation (DO->IT). Accordingly, we will: • Define a programme strategy that ensures quality, consistency and sustainability of health outcomes related activities across individual BD4BO projects. • Integrate, synthesise, and manage knowledge from all BD4BO projects, making it easily accessible via a single knowledge exchange platform. • Act as pivotal point of collaboration, stakeholder engagement and communication for all BD4BO projects. • Provide transparency and enable the use of patient health data and human biological samples for research purposes by developing minimum data privacy standards for Informed Consent Forms (ICFs) and supporting materials for use by individual BD4BO disease-specific projects and more widely in the Research and Development (R&D) sector.


Amgen 0,00 €
Asociacion Nacional Empresarial de La Industria Farmaceutica 0,00 €
BAYER AG 0,00 €
BOEHRINGER INGELHEIM INTERNATIONALGESELLSCHAFT mbH 0,00 €
CELGENE MANAGEMENT Sàrl 0,00 €
Direktoratet FOR Medisinske Produkter 0,00 €
Eli Lilly and Company Ltd. 0,00 €
European Cancer Patient Coalition 100 644 €
F. HOFFMANN-LA ROCHE AG 0,00 €
Federation Europeenne d'Associations et d'Industries Pharmaceutiques 0,00 €
Folkehelseinstituttet 186 240 €
Glaxosmithkline Research & Development Ltd. 0,00 €
Health IQ Ltd. 0,00 €
IHE, Institutet FOR Halso- och Sjukvardsekonomi AB 453 440 €
Imperial College of Science Technology and Medicine 169 776 €
Institut de Recherches Internationales Servier 0,00 €
Institut National de la Sante et de la Recherche Medicale 96 321 €
INTERSYSTEMS GmbH 0,00 €
Janssen Pharmaceutica N.V. 0,00 €
London School of Economics and Political Science 1 263 850 €
MERCK KGaA 0,00 €
MERCK SHARP & DOHME CORP 0,00 €
National Institute for Health and Care Excellence 298 788 €
NOVARTIS PHARMA AG 0,00 €
Novo Nordisk A/S 0,00 €
Pfizer Ltd. 0,00 €
Sanofi-Aventis Recherche & Developpement 0,00 €
SEMMELWEIS EGYETEM 359 918 €
Tandvards-och Lakemedelsformansverket 149 000 €
The Association of the British Pharmaceutical Industry 0,00 €
THE European Multiple Sclerosis Platform Aisbl 120 745 €
The University of Liverpool 0,00 €
TMF - TECHNOLOGIE UND METHODENPLATTFORM FUR DIE VERNETZTE MEDIZINISCHE FORSCHUNG e. V. 231 190 €
UCB Biopharma 0,00 €
Universita Commerciale Luigi Bocconi 119 921 €
VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER e. V. 0,00 €

https://cordis.europa.eu/project/id/116055

Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.